Bibliography

Export 24 results:

Filters: Keyword is Drug Therapy, Combination [Clear All Filters]

2014

Hsiao H-, Liu Y-, Wang H-, Wu C-, Cho S-, Hsu J-, et al. Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant. Transplant infectious disease : an official journal of the Transplantation Society// Transpl Infect Dis. 2014;16(6):1003-6.

2010

Chaurasia S, Muralidhar R, Garg P, Gopinathan U. Donor corneal button-related endophthalmitis after penetrating keratoplasty. Clin Experiment Ophthalmol. 2010;38(1):75-6.

Osawa R, Alexander BD, Lortholary O, Dromer F, Forrest GN, Lyon GM, et al. Identifying predictors of central nervous system disease in solid organ transplant recipients with cryptococcosis. Transplantation. 2010;89(1):69-74.

2009

Tascini C, Urbani L, Doria R, Catalano G, Leonildi A, Filipponi F, et al. Breakthrough Fusarium spp fungemia during caspofungin therapy in an ABO-incompatible orthotopic liver transplant patient. J Chemother. 2009;21(2):236-8.

Caldwell MC, Perfect JR, Carlson AN, Proia AD. Candida glabrata endophthalmitis following penetrating keratoplasty. J Cataract Refract Surg. 2009;35(3):598-602.

Oh JY, Lee MJ, Wee WR, Heo JW. A case of necrotizing sclerokeratitis and endophthalmitis caused by Beauveria bassiana. Jpn J Ophthalmol. 2009;53(5):551-3.

Jurawan R, de Almeida M, Smith A, Weilert F. Swine H1N1 influenza in a post liver transplant patient. N Z Med J. 2009;122(1304):107-11.

Huston JM, Eachempati SR, Rodney JR, Cayci C, Fusco D, Mathew M, et al. Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient. Transpl Infect Dis. 2009;11(3):277-80.

2008

Kaul DR, Lowe L, Visvesvara GS, Farmen S, Khaled YA, Yanik GA. Acanthamoeba infection in a patient with chronic graft-versus-host disease occurring during treatment with voriconazole. Transpl Infect Dis. 2008;10(6):437-41.

Soyama A, Eguchi S, Takatsuki M, Ichikawa T, Moriuchi M, Moriuchi H, et al. Human T-cell leukemia virus type I-associated myelopathy following living-donor liver transplantation. Liver Transpl. 2008;14(5):647-50.

2006

Al-Assiri A, Al-Jastaneiah S, Al-Khalaf A, Al-Fraikh H, Wagoner MD. Late-onset donor-to-host transmission of Candida glabrata following corneal transplantation. Cornea. 2006;25(1):123-5.

Mejia GA, Alvarez CA, Pulido HH, Ramírez B, Cardozo C, Suárez Y, et al. Malaria in a liver transplant recipient: a case report. Transplant Proc. 2006;38(9):3132-4.

2005

Rogers CC, Alloway RR, Buell JF, Boardman R, Alexander JW, Cardi M, et al. Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation. 2005;80(1):26-33.

Rogers CC, Hanaway M, Alloway RR, Alexander JW, Boardman RE, Trofe J, et al. Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy. Transplant Proc. 2005;37(2):795-7.

Alloway RR, Hanaway MJ, Trofe J, Boardman R, Rogers CC, Hanaway MJ, et al. A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience. Transplant Proc. 2005;37(2):802-3.

2002

Husted TL, Buell JF, Hanaway MJ, Trofe J, Beebe T, Gross T, et al. De novo sarcomas in solid organ transplant recipients. Transplant Proc. 2002;34(5):1786-7.

1999

Karakayali H, Moray G, Demirag A, Turan M, Bilgin N, Haberal M. Long-term follow-up of ABO-incompatible renal transplant recipients. Transplant Proc. 1999;31(40575):256-7.

1998

Zhang H, Dornadula G, Beumont M, Livornese L, Van Uitert B, Henning K, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med. 1998;339(25):1803-9.

Nakamura N, Arakaki Y, Sunagawa H, Shiohira Y, Uehara H, Miyasato T, et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplantation proceedings//Transplant Proc. 1998;30(4):1324-6.

Nakamura N, Arakaki Y, Sunagawa H, Shiohira Y, Uehara H, Miyasato T, et al. Influence of immunosuppression in HTLV-1-positive renal transplant recipients. Transplant Proc. 1998;30(4):1324-6.

1994

Anderlini P, Przepiorka D, Luna M, Langford L, Andreeff M, Claxton D, et al. Acanthamoeba meningoencephalitis after bone marrow transplantation. Bone Marrow Transplant. 1994;14(3):459-61.

1989

First MR, Smith RD, Weiss MA, Schroeder TJ, Kant KS, Munda R, et al. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation. Transplant Proc. 1989;21(1 Pt 2):1567-70.

1988

Shah B, First MR, Munda R, Penn I, Fidler JP, Alexander JW. Current experience with renal transplantation in older patients. Am J Kidney Dis. 1988;12(6):516-23.

1986

First MR, Alexander JW, Wadhwa N, Penn I, Munda R, Fidler JP, et al. The use of low doses of cyclosporine, azathioprine, and prednisone in renal transplantation. Transplant Proc. 1986;18(2 Suppl 1):132-5.